Molecular characteristics

Patients have a mutation in the ACER3 gene that makes the enzyme that breaks down a type of fat, called ceramide. The mutation kills ACER3, thus increasing the concentration of ceramide in brain cells, such as neurons. Increased ceramide kills neurons and impairs myelin sheath that wraps neurons, thus leading to neurodegeneration and leukodystrophy.